-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
- Cosmetic Ingredient
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Under the normalization of centralized procurement, the downward trend of drug prices has become the general trend of the industry.
The active price reduction of pharmaceutical companies is not only to comply with the market, but also the result of the combined effect of online price supervision and credit evaluation
.
Recently, news of voluntary price cuts of drugs has been released in many places
.
For example, on September 16, the Sichuan Pharmaceutical Equipment Bidding and Purchasing Service Center announced the active price reduction information for 110 drugs, involving 64 pharmaceutical companies in the special zone drugs and price linkage zone drugs, including Xinda, Kexing, Qilu, Zhengda Tianqing , Baiyunshan, Sinopharm, Simcere, Yangtze River, China Resources Onde, Chengdu Beite, Hunan Sailong, Shanghai Pharmaceutical Holdings, Xinlitai (Suzhou) and other pharmaceutical companies are included in the list of price cuts.
.
On August 10, the Liaoning Province Drug and Medical Consumables Centralized Procurement Network issued the "Notice on the Result of Active Price Reduction of 440 Drugs including Pemetrexed Disodium for Injection"
.
According to the document, the provincial public resource trading center received 440 drugs bids from Yangzijiang Pharmaceutical Group Jiangsu Yangzijiang Pharmaceutical Management Co.
, Ltd.
, CSPC Ouyi Pharmaceutical Co.
, Ltd.
, Hainan Lingkang Pharmaceutical Co.
, Ltd.
and other companies to actively cut prices in Liaoning Province According to the "Implementation Plan for Centralized Procurement of Medicines in Medical Institutions of Liaoning Province", it was agreed to adjust the online purchase price of the above-mentioned products
.
On July 27, the Hunan Provincial Public Resources Trading Center issued the "Announcement on the Adjustment of the Prices of Certain Drugs on the Internet".
According to the announcement, a total of 20 product regulations applied for price reductions
.
Among them, Xi'an Janssen's daratumumab injection (specification: 400mg/20ml) was reduced from 19710 yuan to 8512.
4 yuan, and the 100mg/5ml specification was reduced from 5460 yuan to 2358 yuan, a decrease of 56.
8%
.
In addition, the Shaanxi Provincial Drug Centralized Procurement Platform and the Heilongjiang Centralized Procurement Network have also successively issued notices stating that they have received active price reduction applications from many pharmaceutical companies, which involve a number of imported original research products, including the anti-hyperkalemia drug sodium zirconium cyclosilicate powder.
, Psoriasis drugs, Uselumumab, etc.
, the price reduction ranges from 30% to 50%
.
Faced with the active price cuts of many pharmaceutical companies, it is not difficult to see that the price war for medicines has begun
.
Analysts pointed out that the choice of pharmaceutical companies to cut prices during this period of time may be related to the development layout of the company, the adjustment of the medical insurance catalog and other reasons.
.
At the same time, the active price reduction of pharmaceutical companies is also inseparable from the stricter supervision of online prices by provincial recruitment agencies
.
For example, on August 13, the Sichuan Pharmaceutical Equipment Bidding and Purchasing Service Center announced the "Sichuan Province Pharmaceutical Equipment Centralized Procurement and Pharmaceutical Price Monitoring Platform Online Drug Price Monitoring Regulations".
All products listed on the Sichuan platform are included in their prices.
The scope of drug price monitoring includes the purchase of drugs in quantity, the purchase of drugs based on price linkage, and the purchase of drugs on record
.
In accordance with the above specifications, the price of the online product is within 50% (excluding 50%) compared with the average purchase price of the same manufacturer, the same drug name, the same dosage form product, and the average purchase price in the past three years.
Product prices are marked as green zone prices; product prices with a price increase of 50% (including 50%)-100% (excluding 100%) are marked as yellow zone prices; products with a price increase of more than 100% are marked as red District price price
.
In addition, the monitoring results form a monthly report, which is reported to the Provincial Medical Security Bureau and the Provincial Commission for Discipline Inspection on a regular basis, and is sent to the medical institutions involved
.
This also means that if the product of the drug company linked to the network is marked as a red zone or even a yellow zone price, it is likely to be "passed"
.
Strict price regulation will make drug prices more reasonable
.
The illegal operators will naturally be punished accordingly
.
For example, during the first round of "Inter-Provincial Price Linkage" in Hunan Province this year, 13 pharmaceutical companies failed to truthfully fill in the lowest online price information from other provinces and had dishonesty behaviors.
They were assessed as "general dishonesty" by the Hunan Provincial Pharmaceutical Centralized Procurement Platform.
"
.
In addition, in Shaanxi, there are also many companies’ price-limiting online products because they violated the “Shaanxi Provincial Public Resources Trading Center Drug Sunshine Internet Dynamic Adjustment Implementation Plan” proposed by the "price-limiting online catalog products, if there is a new national minimum At the time of the price, the manufacturer of the network must declare to the provincial platform within one month from the date of implementation of the price
.
If it fails to declare in time or truthfully, once verified, the qualification of the product to be connected to the network shall be cancelled and recorded in the enterprise’s integrity file.
During the year, the product declaration requirement was not accepted, which resulted in the disqualification of the online connection and the entry of the company’s integrity file
.
Judging from the current attitudes towards centralized procurement of drugs in all regions, there is almost a consistent price reduction requirement.
With the continuous advancement of national centralized procurement, under the situation of increasing market competition, whether it is selected or not selected, price reductions will become the general trend
.
In this regard, the industry believes that in accordance with the timetable for the medical improvement development and the release of many reform policy documents, more and more pharmaceutical companies may take such measures in the future to actively seek price reductions in more cities and cover more markets.
.
The active price reduction of pharmaceutical companies is not only to comply with the market, but also the result of the combined effect of online price supervision and credit evaluation
.
Recently, news of voluntary price cuts of drugs has been released in many places
.
For example, on September 16, the Sichuan Pharmaceutical Equipment Bidding and Purchasing Service Center announced the active price reduction information for 110 drugs, involving 64 pharmaceutical companies in the special zone drugs and price linkage zone drugs, including Xinda, Kexing, Qilu, Zhengda Tianqing , Baiyunshan, Sinopharm, Simcere, Yangtze River, China Resources Onde, Chengdu Beite, Hunan Sailong, Shanghai Pharmaceutical Holdings, Xinlitai (Suzhou) and other pharmaceutical companies are included in the list of price cuts.
.
On August 10, the Liaoning Province Drug and Medical Consumables Centralized Procurement Network issued the "Notice on the Result of Active Price Reduction of 440 Drugs including Pemetrexed Disodium for Injection"
.
According to the document, the provincial public resource trading center received 440 drugs bids from Yangzijiang Pharmaceutical Group Jiangsu Yangzijiang Pharmaceutical Management Co.
, Ltd.
, CSPC Ouyi Pharmaceutical Co.
, Ltd.
, Hainan Lingkang Pharmaceutical Co.
, Ltd.
and other companies to actively cut prices in Liaoning Province According to the "Implementation Plan for Centralized Procurement of Medicines in Medical Institutions of Liaoning Province", it was agreed to adjust the online purchase price of the above-mentioned products
.
On July 27, the Hunan Provincial Public Resources Trading Center issued the "Announcement on the Adjustment of the Prices of Certain Drugs on the Internet".
According to the announcement, a total of 20 product regulations applied for price reductions
.
Among them, Xi'an Janssen's daratumumab injection (specification: 400mg/20ml) was reduced from 19710 yuan to 8512.
4 yuan, and the 100mg/5ml specification was reduced from 5460 yuan to 2358 yuan, a decrease of 56.
8%
.
In addition, the Shaanxi Provincial Drug Centralized Procurement Platform and the Heilongjiang Centralized Procurement Network have also successively issued notices stating that they have received active price reduction applications from many pharmaceutical companies, which involve a number of imported original research products, including the anti-hyperkalemia drug sodium zirconium cyclosilicate powder.
, Psoriasis drugs, Uselumumab, etc.
, the price reduction ranges from 30% to 50%
.
Faced with the active price cuts of many pharmaceutical companies, it is not difficult to see that the price war for medicines has begun
.
Analysts pointed out that the choice of pharmaceutical companies to cut prices during this period of time may be related to the development layout of the company, the adjustment of the medical insurance catalog and other reasons.
.
At the same time, the active price reduction of pharmaceutical companies is also inseparable from the stricter supervision of online prices by provincial recruitment agencies
.
For example, on August 13, the Sichuan Pharmaceutical Equipment Bidding and Purchasing Service Center announced the "Sichuan Province Pharmaceutical Equipment Centralized Procurement and Pharmaceutical Price Monitoring Platform Online Drug Price Monitoring Regulations".
All products listed on the Sichuan platform are included in their prices.
The scope of drug price monitoring includes the purchase of drugs in quantity, the purchase of drugs based on price linkage, and the purchase of drugs on record
.
In accordance with the above specifications, the price of the online product is within 50% (excluding 50%) compared with the average purchase price of the same manufacturer, the same drug name, the same dosage form product, and the average purchase price in the past three years.
Product prices are marked as green zone prices; product prices with a price increase of 50% (including 50%)-100% (excluding 100%) are marked as yellow zone prices; products with a price increase of more than 100% are marked as red District price price
.
In addition, the monitoring results form a monthly report, which is reported to the Provincial Medical Security Bureau and the Provincial Commission for Discipline Inspection on a regular basis, and is sent to the medical institutions involved
.
This also means that if the product of the drug company linked to the network is marked as a red zone or even a yellow zone price, it is likely to be "passed"
.
Strict price regulation will make drug prices more reasonable
.
The illegal operators will naturally be punished accordingly
.
For example, during the first round of "Inter-Provincial Price Linkage" in Hunan Province this year, 13 pharmaceutical companies failed to truthfully fill in the lowest online price information from other provinces and had dishonesty behaviors.
They were assessed as "general dishonesty" by the Hunan Provincial Pharmaceutical Centralized Procurement Platform.
"
.
In addition, in Shaanxi, there are also many companies’ price-limiting online products because they violated the “Shaanxi Provincial Public Resources Trading Center Drug Sunshine Internet Dynamic Adjustment Implementation Plan” proposed by the "price-limiting online catalog products, if there is a new national minimum At the time of the price, the manufacturer of the network must declare to the provincial platform within one month from the date of implementation of the price
.
If it fails to declare in time or truthfully, once verified, the qualification of the product to be connected to the network shall be cancelled and recorded in the enterprise’s integrity file.
During the year, the product declaration requirement was not accepted, which resulted in the disqualification of the online connection and the entry of the company’s integrity file
.
Judging from the current attitudes towards centralized procurement of drugs in all regions, there is almost a consistent price reduction requirement.
With the continuous advancement of national centralized procurement, under the situation of increasing market competition, whether it is selected or not selected, price reductions will become the general trend
.
In this regard, the industry believes that in accordance with the timetable for the medical improvement development and the release of many reform policy documents, more and more pharmaceutical companies may take such measures in the future to actively seek price reductions in more cities and cover more markets.
.
